New This Month | New This Year | Abstract | TRITE Statistics | Disclaimer

Results - FULL MEDLINE:

Western equine encephalitis virus is a recombinant virus. C S Hahn ... J H Strauss Proc Natl Acad Sci U S A 1988 Aug; 85(16)5997-6001. Score: 0.847 Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination. Stuart D Perkins ... Robert J Phillpotts Vaccine 2006 Apr; 24(17)3440-5. Score: 0.771 Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. Slobodan Paessler ... Ilya Frolov J Virol 2006 Mar; 80(6)2784-96. Score: 0.737 Molecular epidemiological studies of veterinary arboviral encephalitides. S C Weaver ... A D Barrett Vet J 1999 Mar; 157(2)123-38. Score: 0.694 Host range, amplification and arboviral disease emergence. S C Weaver Arch Virol Suppl 2005 ; (19)33-44. Score: 0.685 Detection of antibodies to alphaviruses and discrimination between antibodies to eastern and western equine encephalitis viruses in rabbit sera using a recombinant antigen and virus-specific monoclonal antibodies. S Pässler ... M Pfeffer J Vet Med B Infect Dis Vet Public Health 2003 Aug; 50(6)265-9. Score: 0.684 Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. Slobodan Paessler ... Ilya Frolov J Virol 2003 Sep; 77(17)9278-86. Score: 0.681 Replication of alphaviruses in cultures of donkey monocytes. F Liprandi ... R Walder Arch Virol 1986 ; 87(3-4)163-71. Score: 0.670 Immunologic interference from sequential administration of live attenuated alphavirus vaccines. D J McClain ... F J Malinoski J Infect Dis 1998 Mar; 177(3)634-41. Score: 0.649 DNA shuffling and screening strategies for improving vaccine efficacy. Christopher P Locher ... Juha Punnonen DNA Cell Biol 2005 Apr; 24(4)256-63. Score: 0.632 Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus. R J Phillpotts ... A Bennett Vaccine 2005 Feb; 23(13)1615-23. Score: 0.615 Current status of flavivirus vaccines. A D Barrett Ann N Y Acad Sci 2001 Dec; 951()262-71. Score: 0.571 Venezuelan equine encephalitis virus entry mechanism requires late endosome formation and resists cell membrane cholesterol depletion. Andrey A Kolokoltsov ... Robert A Davey Virology 2006 Apr; 347(2)333-42. Score: 0.570 Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunization with the attenuated vaccine strain TC-83. R J Phillpotts Vaccine 1999 May; 17(19)2429-35. Score: 0.564 Replication-defective viruses as vaccines and vaccine vectors. Tim Dudek ... David M Knipe Virology 2006 Jan; 344(1)230-9. Score: 0.557 Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. P Pushko ... J Smith J Virol 2001 Dec; 75(23)11677-85. Score: 0.556 Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Ching-Juh Lai ... Thomas P Monath Adv Virus Res 2003 ; 61()469-509. Score: 0.541 Preparation and testing of vaccines prepared from the envelopes of Venezuelan, eastern, and western equine encephalomyelitis viruses. C E Pedersen J Clin Microbiol 1976 Feb; 3(2)113-8. Score: 0.537 Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins. Andrey A Kolokoltsov ... Robert A Davey J Virol 2005 Jan; 79(2)756-63. Score: 0.535 Chimeric virus-like particles as vaccines. D H Krüger ... W H Gerlich Biol Chem 1999 Mar; 380(3)275-6. Score: 0.532 Studies of arboviruses in Southwestern Venezuela: I. Isolations of Venezuelan and Eastern Equine Encephalitis viruses from sentinel hamsters in the Catatumbo region. R Walder ... O M Suárez Int J Epidemiol 1976 Dec; 5(4)375-8. Score: 0.528 Particle-based vaccines for HIV-1 infection. Kelly R Young ... Ted M Ross Curr Drug Targets Infect Disord 2003 Jun; 3(2)151-69. Score: 0.525 Immunogens of encephalitis viruses. J T Roehrig Vet Microbiol 1993 Nov; 37(3-4)273-84. Score: 0.525 Venezuelan equine encephalitis. Scott C Weaver ... Juan-Carlos Navarro Annu Rev Entomol 2004 ; 49()141-74. Score: 0.525 Vaccine research efforts for filoviruses. Mary Kate Hart Int J Parasitol 2003 May; 33(5-6)583-95. Score: 0.520 Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus. Stephen J Elvin ... Robert J Phillpotts J Med Virol 2002 Jul; 67(3)384-93. Score: 0.515 Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV. R J Phillpotts ... S C Jacobs Acta Virol 2000 Oct; 44(5)233-9. Score: 0.511 Venezuelan equine encephalitis virus in the guinea pig model: evidence for epizootic virulence determinants outside the E2 envelope glycoprotein gene. Ivorlyne P Greene ... Scott C Weaver Am J Trop Med Hyg 2005 Mar; 72(3)330-8. Score: 0.507 Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice. M K Hart ... G V Ludwig Vaccine 2001 Nov; 20(3-4)616-22. Score: 0.506 Structure of isolated nucleocapsids from venezuelan equine encephalitis virus and implications for assembly and disassembly of enveloped virus. Angel Paredes ... Stanley J Watowich J Virol 2003 Jan; 77(1)659-64. Score: 0.503 Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. William D Pratt ... Jonathan F Smith Vaccine 2003 Sep; 21(25-26)3854-62. Score: 0.496 Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. M K Hart ... K Steele Vaccine 2000 Jul; 18(26)3067-75. Score: 0.496 Alphavirus vectors and vaccination. Jonathan O Rayner ... Kurt I Kamrud Rev Med Virol 2002 Sep-Oct; 12(5)279-96. Score: 0.495 Development of new vaccines against dengue fever and Japanese encephalitis. R M Kinney ... C Y Huang Intervirology 2001 ; 44(2-3)176-97. Score: 0.492 Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice. L D Jones ... R J Phillpotts Virus Res 2003 Feb; 91(2)255-9. Score: 0.492 SIV/HIV-1 chimeric viruses having HIV-1 env gene: a new animal model and a candidate for attenuated live vaccine. M Hayami ... T Igarashi Leukemia 1997 Apr; 11 Suppl 3()95-7. Score: 0.490 Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus. R J Phillpotts ... S C Howard Vaccine 2002 Feb; 20(11-12)1497-504. Score: 0.485 Viral vectors for use in the development of biodefense vaccines. John S Lee ... Michael D Parker Adv Drug Deliv Rev 2005 Jun; 57(9)1293-314. Score: 0.484 Potential sources of the 1995 Venezuelan equine encephalitis subtype IC epidemic. A C Brault ... S C Weaver J Virol 2001 Jul; 75(13)5823-32. Score: 0.483 Examples of expression systems based on animal RNA viruses: alphaviruses and influenza virus. C M Rice Curr Opin Biotechnol 1992 Oct; 3(5)523-32. Score: 0.478 Generation and characterization of closely related epizootic and enzootic infectious cDNA clones for studying interferon sensitivity and emergence mechanisms of Venezuelan equine encephalitis virus. Michael Anishchenko ... Scott C Weaver J Virol 2004 Jan; 78(1)1-8. Score: 0.478 Eastern equine encephalitis in dogs. Michele D Farrar ... Clint L Hall J Vet Diagn Invest 2005 Nov; 17(6)614-7. Score: 0.477 TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus. R J Phillpotts ... A J Wright Vaccine 1999 Feb; 17(7-8)982-8. Score: 0.476 ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. Juan Arroyo ... Thomas P Monath J Virol 2004 Nov; 78(22)12497-507. Score: 0.474 Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine. T Kuwata ... M Hayami Trends Microbiol 2001 Oct; 9(10)475-80. Score: 0.469 Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation. Michael Anishchenko ... Scott C Weaver Proc Natl Acad Sci U S A 2006 Mar; 103(13)4994-9. Score: 0.468 Improvements in live-attenuated HIV vaccines? Immunol Today 1996 Sep; 17(9)401. Score: 0.467 An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector. Silvia Perri ... John M Polo J Virol 2003 Oct; 77(19)10394-403. Score: 0.466 Virus-like particles: a new family of delivery systems. Florence Boisgérault ... Claude Leclerc Expert Rev Vaccines 2002 Jun; 1(1)101-9. Score: 0.465 Towards an AIDS vaccine: the role of nonhuman primates. N Nathanson ... B J Mathieson J Med Primatol 1999 Aug-Oct; 28(4-5)146-53. Score: 0.464 Flavivirus DNA vaccines: current status and potential. G J Chang ... G Kuno Ann N Y Acad Sci 2001 Dec; 951()272-85. Score: 0.462 Simultaneous identification of orthopoxviruses and alphaviruses by oligonucleotide macroarray with special emphasis on detection of variola and Venezuelan equine encephalitis viruses. Joseph E Fitzgibbon ... Jose-Luis Sagripanti J Virol Methods 2006 Feb; 131(2)160-7. Score: 0.461 Eastern equine encephalomyelitis virus infection in a horse from California. Robert P Franklin ... Michael D Parker Emerg Infect Dis 2002 Mar; 8(3)283-8. Score: 0.460 Vaccines for viruses. D N WALCHER Med Clin North Am 1961 Jul; 45()1081-93. Score: 0.460 Vector infection determinants of Venezuelan equine encephalitis virus reside within the E2 envelope glycoprotein. Aaron C Brault ... Scott C Weaver J Virol 2002 Jun; 76(12)6387-92. Score: 0.459 Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. C Y Huang ... R M Kinney J Virol 2000 Apr; 74(7)3020-8. Score: 0.458 Virus-like particles as immunogens. Rob Noad ... Polly Roy Trends Microbiol 2003 Sep; 11(9)438-44. Score: 0.457 Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells. Olga Petrakova ... Ilya Frolov J Virol 2005 Jun; 79(12)7597-608. Score: 0.456 Clinical, pathologic, immunohistochemical, and virologic findings of eastern equine encephalomyelitis in two horses. F Del Piero ... C Cantile Vet Pathol 2001 Jul; 38(4)451-6. Score: 0.456 Alphavirus vectors: development and potential therapeutic applications. S Schlesinger Expert Opin Biol Ther 2001 Mar; 1(2)177-91. Score: 0.455 Papillomavirus virus-like particles as anticancer vaccines. D M Da Silva ... W M Kast Curr Opin Mol Ther 1999 Feb; 1(1)82-8. Score: 0.452 Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics. Brian R Murphy ... Peter L Collins J Clin Invest 2002 Jul; 110(1)21-7. Score: 0.451 Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus. Douglas S Reed ... Michael D Parker Vaccine 2005 May; 23(24)3139-47. Score: 0.451 Evaluation in nonhuman primates of vaccines against Ebola virus. Thomas W Geisbert ... Peter B Jahrling Emerg Infect Dis 2002 May; 8(5)503-7. Score: 0.450 Persistence of alphaviruses in vertebrate hosts. B Levine ... D E Griffin Trends Microbiol 1994 Jan; 2(1)25-8. Score: 0.449 Efficacy of DNA vaccination against western equine encephalitis virus infection. Les P Nagata ... Jonathan P Wong Vaccine 2005 Mar; 23(17-18)2280-3. Score: 0.448 Chimeric Sindbis-Ross River viruses to study interactions between alphavirus nonstructural and structural regions. R J Kuhn ... J H Strauss J Virol 1996 Nov; 70(11)7900-9. Score: 0.447 Toward novel vaccines and therapies based on negative-strand RNA viruses. V von Messling ... R Cattaneo Curr Top Microbiol Immunol 2004 ; 283()281-312. Score: 0.446 Eastern equine encephalitis in a free-ranging white-tailed deer (Odocoileus virginianus). Cynthia M Tate ... Daniel G Mead J Wildl Dis 2005 Jan; 41(1)241-5. Score: 0.445 Virus-like particles as HIV-1 vaccines. Linh X Doan ... Qizhi Yao Rev Med Virol 2005 Mar-Apr; 15(2)75-88. Score: 0.444 A rapid diagnostic assay for eastern equine encephalomyelitis viral RNA. M H Vodkin ... R J Novak Am J Trop Med Hyg 1993 Dec; 49(6)772-6. Score: 0.441 Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic venezuelan equine encephalitis virus. Ivorlyne P Greene ... Scott C Weaver J Virol 2005 Jul; 79(14)9128-33. Score: 0.441 Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties. Sophie Broche-Pierre ... Pierre Sonigo J Gen Virol 2005 Sep; 86(Pt 9)2495-506. Score: 0.440 Enhanced lymphoproliferation to influenza A virus following vaccination of older, chronically ill adults with live-attenuated viruses. G J Gorse ... R B Belshe Scand J Infect Dis 1991 ; 23(1)7-17. Score: 0.439 Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases. A McAllister ... R Andino J Virol 2000 Oct; 74(19)9197-205. Score: 0.439 Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus. Claire Y-H Huang ... Richard M Kinney J Virol 2005 Jun; 79(12)7300-10. Score: 0.438 Complete sequence of the genomic RNA of O'nyong-nyong virus and its use in the construction of alphavirus phylogenetic trees. R S Levinson ... E G Strauss Virology 1990 Mar; 175(1)110-23. Score: 0.434 Recombinant chimeric western and eastern equine encephalitis viruses as potential vaccine candidates. Randal J Schoepp ... Michael D Parker Virology 2002 Oct; 302(2)299-309. Score: 0.433 Aerosol infection of cynomolgus macaques with enzootic strains of venezuelan equine encephalitis viruses. Douglas S Reed ... Michael D Parker J Infect Dis 2004 Mar; 189(6)1013-7. Score: 0.433 Virology--11th international congress. 9-13 August 1999, Sydney, Australia. A Fooks IDrugs 1999 Nov; 2(11)1136-8. Score: 0.431 Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. P B Jahrling ... E H Stephenson J Clin Microbiol 1984 Mar; 19(3)429-31. Score: 0.431 The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: development of new live flavivirus vaccines. M C Bonaldo ... R Galler Mem Inst Oswaldo Cruz 2000 ; 95 Suppl 1()215-23. Score: 0.431 Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection. R A Lukaszewski ... T J Brooks J Virol 2000 Jun; 74(11)5006-15. Score: 0.431 Persistence in humans of antibody after immunization with four alphavirus vaccines. J L DeMeio ... W J Thomas Asian J Infect Dis 1979 Sep; 3(3)119-24. Score: 0.429 Alphavirus vectors for cancer gene therapy (review). Ryuya Yamanaka Int J Oncol 2004 Apr; 24(4)919-23. Score: 0.428 Experience with live-attenuated varicella-zoster vaccines. P LaRussa Contrib Microbiol 1999 ; 3()173-92. Score: 0.427 Eastern equine encephalomyelitis virus infection in swine. F Elvinger ... W B Nessmith J Am Vet Med Assoc 1994 Oct; 205(7)1014-6. Score: 0.425 Evolution of live-attenuated virus vaccines. B Berkhout ... K Verhoef Dev Biol (Basel) 2001 ; 106()217-21; discussion 253-63. Score: 0.424 Confronting the avian influenza threat: vaccine development for a potential pandemic. Iain Stephenson ... Jacqueline M Katz Lancet Infect Dis 2004 Aug; 4(8)499-509. Score: 0.424 Candidate vaccines protect macaques against primate immunodeficiency viruses. J Stott ... N Almond AIDS Res Hum Retroviruses 1998 Oct; 14 Suppl 3()S265-70. Score: 0.421 The hamster as an animal model for eastern equine encephalitis--and its use in studies of virus entrance into the brain. Slobodan Paessler ... Scott C Weaver J Infect Dis 2004 Jun; 189(11)2072-6. Score: 0.420 Antibody and interleukin-12 treatment in murine models of encephalitogenic flavivirus (St. Louis encephalitis, tick-borne encephalitis) and alphavirus (Venezuelan equine encephalitis) infection. R J Phillpotts ... T J G Brooks J Interferon Cytokine Res 2003 Jan; 23(1)47-50. Score: 0.420 Japanese encephalitis vaccines: moving away from the mouse brain. Mark P Zanin ... Steven L Wesselingh Expert Rev Vaccines 2003 Jun; 2(3)407-16. Score: 0.420 Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved? Alexander Bukreyev ... Igor M Belyakov Expert Rev Vaccines 2002 Aug; 1(2)233-45. Score: 0.420 Transmission cycles, host range, evolution and emergence of arboviral disease. Scott C Weaver ... Alan D T Barrett Nat Rev Microbiol 2004 Oct; 2(10)789-801. Score: 0.420 An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine. A M Bennett ... R J Phillpotts Vaccine 2000 Sep; 19(2-3)337-47. Score: 0.417 Empirically derived live-attenuated vaccines against dengue and Japanese encephalitis. Jean-François Saluzzo Adv Virus Res 2003 ; 61()419-43. Score: 0.416 Genetic characterization of an antigenic subtype of eastern equine encephalomyelitis virus. S C Weaver ... C H Calisher Arch Virol 1992 ; 127(1-4)305-14. Score: 0.416 A comparison of the nucleotide sequences of eastern and western equine encephalomyelitis viruses with those of other alphaviruses and related RNA viruses. S C Weaver ... D W Trent Virology 1994 Aug; 202(2)1083. Score: 0.416 The alphaviruses: gene expression, replication, and evolution. J H Strauss ... E G Strauss Microbiol Rev 1994 Sep; 58(3)491-562. Score: 0.415 Live attenuated AIDS viruses as vaccines: promise or peril? R M Ruprecht Immunol Rev 1999 Aug; 170()135-49. Score: 0.415 Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components. Taisuke Horimoto ... Yoshihiro Kawaoka Microbes Infect 2004 May; 6(6)579-83. Score: 0.414 Progress on new vaccine strategies against chronic viral infections. Jay A Berzofsky ... Igor M Belyakov J Clin Invest 2004 Aug; 114(4)450-62. Score: 0.414 Live-attenuated HIV vaccines: how safe is safe enough? M Murphey-Corb Nat Med 1997 Jan; 3(1)17-8. Score: 0.413 Venezuelan equine encephalomyelitis virus structure and its divergence from old world alphaviruses. A Paredes ... S J Watowich J Virol 2001 Oct; 75(19)9532-7. Score: 0.413 Growth patterns of temperature-sensitive mutants of Western equine encephalitis virus in cultured Aedes albopictus (mosquito) cells. B Simizu ... S Maeda J Gen Virol 1981 Oct; 56(Pt 2)349-61. Score: 0.412 Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. T J Chambers ... C M Rice J Virol 1999 Apr; 73(4)3095-101. Score: 0.409 Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines. Kenneth H Eckels ... Robert Putnak Adv Virus Res 2003 ; 61()395-418. Score: 0.409 Venezuelan equine encephalitis virus, southern Mexico. José G Estrada-Franco ... Scott C Weaver Emerg Infect Dis 2004 Dec; 10(12)2113-21. Score: 0.407 Antigenic relationships of alphaviruses by a simple micro-culture cross-neutralization method. A C Chanas ... D I Simpson J Gen Virol 1976 Aug; 32(2)295-300. Score: 0.407 Susceptibility of Psorophora confinnis (Diptera: Culicidae) to infection with epizootic (subtype IC) and enzootic (subtype ID) Venezuelan Equine encephalitis viruses. Diana I Ortiz ... Scott C Weaver J Med Entomol 2005 Sep; 42(5)857-63. Score: 0.406 [Progress in developing viral polynucleotide (DNA) vaccines] Iu Z Gendon Vopr Virusol 1999 Jul-Aug; 44(4)148-54. Score: 0.406 Features of cross protection between Sindbis and Venezuelan equine encephalitis viruses in mice--relationship of route of immunization to protection. D L Fine ... L B Wilkins J Gen Virol 1974 Sep; 24(3)401-8. Score: 0.404 Equine influenza vaccine efficacy: the significance of antigenic variation. P Yates ... J A Mumford Vet Microbiol 2000 May; 74(1-2)173-7. Score: 0.404 Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines. J E Crowe Vaccine 1998 Aug-Sep; 16(14-15)1423-32. Score: 0.403 Vaccines against Aujeszky's disease: comparison of efficacy, DNA fingerprints and antibody response to glycoprotein I. J T van Oirschot ... A L Gielkens Vet Q 1987 Nov; 9 Suppl 1()37S-49S. Score: 0.403 Biodefense. Has biodefense gone overboard? Martin Enserink ... Jocelyn Kaiser Science 2005 Mar; 307(5714)1396-8. Score: 0.402 Emerging viruses, emerging threat. B J Culliton Science 1990 Jan; 247(4940)279-80. Score: 0.401 Biodefense. Smallpox vaccines: looking beyond the next generation. Martin Enserink Science 2004 May; 304(5672)809. Score: 0.400 Efficacy and immune response to rubella subunits vaccines. R Cappel ... F De Cuyper Arch Virol 1976 ; 50(3)207-13. Score: 0.400 More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved? Alexander Bukreyev ... Alexander C Schmidt Proc Natl Acad Sci U S A 2002 Dec; 99(26)16987-91. Score: 0.399 Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. U Dittmer ... K J Hasenkrug J Virol 1998 Aug; 72(8)6554-8. Score: 0.398 Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Alexander G Pletnev ... Robert M Chanock Virology 2003 Sep; 314(1)190-5. Score: 0.397 Evaluation of outbreaks of disease attributable to eastern equine encephalitis virus in horses. W A Ross ... J B Kaneene J Am Vet Med Assoc 1996 Jun; 208(12)1988-97. Score: 0.397 Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus. E J Stott ... C Bruck J Gen Virol 1998 Mar; 79 ( Pt 3)()423-32. Score: 0.397 Sensitive and specific colorimetric dot assay to detect eastern equine encephalomyelitis viral RNA in mosquitoes (Diptera: Culicidae) after polymerase chain reaction amplification. P Armstrong ... A Spielman J Med Entomol 1995 Jan; 32(1)42-52. Score: 0.396 Now and future influenza vaccines. F L Ruben Infect Dis Clin North Am 1990 Mar; 4(1)1-10. Score: 0.396 Immunity to aerosol challenge in guinea pigs immunized with gamma-irradiated Venezuelan equine encephalitis vaccines. M Reitman ... E J Tonik Appl Microbiol 1971 Apr; 21(4)688-92. Score: 0.396 Prospects for human papillomavirus vaccine development: emerging HPV vaccines. J F Hines ... A B Jenson Curr Opin Obstet Gynecol 1998 Feb; 10(1)15-9. Score: 0.394 [On the antigenicity of vaccines against poliomyelitis. Inactivated vaccines and vaccinations by attenuated living viruses.] P LEPINE Bull Acad Natl Med 1960 Jun 5-Jul 28; 144()480-98. Score: 0.394 [Immunologic protection against the contamination of antipoliomyelitis vaccines by oncogenic viruses.] G BARSKI C R Hebd Seances Acad Sci 1963 Apr; 256()3776-8. Score: 0.394 Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine. M N Fleeton ... G J Atkins J Gen Virol 2000 Mar; 81(Pt 3)749-58. Score: 0.394 Subunit vaccines against infection by enveloped viruses. B Morein ... S Höglund Adv Biotechnol Processes 1990 ; 14()69-90. Score: 0.394 Live bivalent vaccine for parainfluenza and influenza virus infections. Yasuko Maeda ... Yoshihiro Kawaoka J Virol 2005 Jun; 79(11)6674-9. Score: 0.393 The role of reverse genetics in the development of vaccines against respiratory viruses. G A Marsh ... G A Tannock Expert Opin Biol Ther 2005 Mar; 5(3)369-80. Score: 0.393 Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. Claire Y-H Huang ... Richard M Kinney J Virol 2003 Nov; 77(21)11436-47. Score: 0.393 Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection. X J Da Costa ... D M Knipe Virology 2001 Sep; 288(2)256-63. Score: 0.392 DI particles: painting a clearer picture of viruses and vaccines. C S Marwick Am Pharm 1981 Oct; NS21(10)14-5. Score: 0.392 Genetic determinants of Venezuelan equine encephalitis emergence. S C Weaver ... A M Powers Arch Virol Suppl 2004 ; (18)43-64. Score: 0.392 Protection against viruses. R Cataldo Am Pharm 1992 May; NS32(5)30-2. Score: 0.392 Emerging zoonotic encephalitis viruses: lessons from Southeast Asia and Oceania. John S Mackenzie J Neurovirol 2005 Oct; 11(5)434-40. Score: 0.391 Vaccine research: new vaccines and evidence of vaccine safety. Commun Dis Rep CDR Wkly 1999 May; 9(19)167, 170. Score: 0.391 Improving vaccine performance with adjuvants. F R Vogel Clin Infect Dis 2000 Jun; 30 Suppl 3()S266-70. Score: 0.390 Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys. Stephen S Whitehead ... Brian R Murphy Vaccine 2003 Oct; 21(27-30)4307-16. Score: 0.389 HIV vaccines: brief review and discussion of future directions. Karen S Slobod ... Julia L Hurwitz Expert Rev Vaccines 2005 Jun; 4(3)305-13. Score: 0.389 Vaccines and animal models for arboviral encephalitides. Aysegul Nalca ... Chris A Whitehouse Antiviral Res 2003 Nov; 60(3)153-74. Score: 0.389 A comparison of the nucleotide sequences of eastern and western equine encephalomyelitis viruses with those of other alphaviruses and related RNA viruses. S C Weaver ... D W Trent Virology 1993 Nov; 197(1)375-90. Score: 0.388 [Mutability of viruses of the equine encephalitis group under the influence of alkylating compounds. 2. Genetic characteristics of mutants of eastern and Venezuelan equine encephalitis viruses produced by formaldehyde and by N-nitroso-methyl-urea] R G Solianik ... Iu V Fedorov Rev Roum Virol 1974 ; 25(3)259-63. Score: 0.388 Virus-like particle vaccines for mucosal immunization. M K Estes ... M E Conner Adv Exp Med Biol 1997 ; 412()387-95. Score: 0.388 Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Robert B Tesh ... Thomas P Monath Emerg Infect Dis 2002 Dec; 8(12)1392-7. Score: 0.388 Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques. C Jane Dale ... Stephen J Kent Virology 2002 Sep; 301(1)176-87. Score: 0.387 Live attenuated HIV vaccines: pitfalls and prospects. James B Whitney ... Ruth M Ruprecht Curr Opin Infect Dis 2004 Feb; 17(1)17-26. Score: 0.387 Antibodies, viruses and vaccines. Dennis R Burton Nat Rev Immunol 2002 Sep; 2(9)706-13. Score: 0.386 Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Jenny Riemenschneider ... Connie Schmaljohn Vaccine 2003 Sep; 21(25-26)4071-80. Score: 0.386 Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses. Udeni B R Balasuriya ... N James MacLachlan Vaccine 2002 Feb; 20(11-12)1609-17. Score: 0.385 Reverse genetics on fish rhabdoviruses: tools to study the pathogenesis of fish rhabdoviruses. M Brémont Curr Top Microbiol Immunol 2005 ; 292()119-41. Score: 0.384 Emerging viruses: advances and challenges. Thomas W Geisbert Curr Mol Med 2005 Dec; 5(8)733-4. Score: 0.384 Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge. John S Lee ... Susan L Welkos Infect Immun 2003 Mar; 71(3)1491-6. Score: 0.384 Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques. Douglas S Reed ... Michael D Parker J Infect Dis 2005 Oct; 192(7)1173-82. Score: 0.384 Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors. Kathryn A Hanley ... Alexander G Pletnev Vector Borne Zoonotic Dis 2005 ; 5(1)1-10. Score: 0.384 Efficacy of AIDS vaccine strategies in nonhuman primates. Klaus Uberla Med Microbiol Immunol 2005 Aug; 194(4)201-6. Score: 0.384 Live flavivirus vaccines: reasons for caution. Stephen J Seligman ... Ernest A Gould Lancet 2004 Jun; 363(9426)2073-5. Score: 0.384 Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus. A G Pletnev ... M Bray Virology 2000 Aug; 274(1)26-31. Score: 0.383 Postepizootic persistence of Venezuelan equine encephalitis virus, Venezuela. Juan-Carlos Navarro ... Scott C Weaver Emerg Infect Dis 2005 Dec; 11(12)1907-15. Score: 0.383 Effect of dose on house finch infection with western equine encephalomyelitis and St. Louis encephalitis viruses. William K Reisen ... Sharon Clark J Med Entomol 2004 Sep; 41(5)978-81. Score: 0.383 Traditional and novel approaches to flavivirus vaccines. Konstantin V Pugachev ... Thomas P Monath Int J Parasitol 2003 May; 33(5-6)567-82. Score: 0.382 Molecular evolution of eastern equine encephalomyelitis virus in North America. S C Weaver ... R Rico-Hesse Virology 1991 Jun; 182(2)774-84. Score: 0.382 Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection of mice. A J Wright ... R J Phillpotts Arch Virol 1998 ; 143(6)1155-62. Score: 0.381 Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus. Aaron C Brault ... Scott C Weaver J Virol 2002 Feb; 76(4)1718-30. Score: 0.381 Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon. Rainer Gehrke ... Christian W Mandl J Gen Virol 2005 Apr; 86(Pt 4)1045-53. Score: 0.381 Gene-mutated HIV-1/SIV chimeric viruses as AIDS live attenuated vaccines for potential human use. M Hayami ... M Honda Leukemia 1999 Apr; 13 Suppl 1()S42-7. Score: 0.381 Biodefense research: an emerging conundrum. Ronald M Atlas Curr Opin Biotechnol 2005 Jun; 16(3)239-42. Score: 0.381 Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model. Thomas J Chambers ... Xiaoshan Jiang J Virol 2003 Mar; 77(6)3655-68. Score: 0.380 New approaches to the development of virus vaccines for veterinary use. K Yamanouchi ... C Kai Rev Sci Tech 1998 Dec; 17(3)641-53. Score: 0.380 Biology and application of alphaviruses in gene therapy. K Lundstrom Gene Ther 2005 Oct; 12 Suppl 1()S92-7. Score: 0.379 Structural proteins of Western equine encephalitis virus: amino acid compositions and N-terminal sequences. J R Bell ... B Simizu J Virol 1983 Feb; 45(2)708-14. Score: 0.378 Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. S Z Wang ... R C Montelaro Virology 1994 Feb; 199(1)247-51. Score: 0.378 Venezuelan equine encephalomyelitis virus (VEEV):strain differentiation and specification of virulence markers. R Walder ... C J Bradish J Gen Virol 1975 Mar; 26(3)265-75. Score: 0.378 Effects of viruses and viral vaccines on the CNS. A D Dayan Proc R Soc Med 1975 Sep; 68(9)562. Score: 0.377 Recombinant viral vector vaccines for the veterinary use. N Yokoyama ... T Mikami J Vet Med Sci 1997 May; 59(5)311-22. Score: 0.377 Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses. P S Caufour ... R Galler Virus Res 2001 Nov; 79(1-2)1-14. Score: 0.377 Vaccination with a heterologous respiratory syncytial virus chimeric FG glycoprotein demonstrates significant subgroup cross-reactivity. N L Oien ... M W Wathen Vaccine 1993 ; 11(10)1040-8. Score: 0.377 Immunogenicity of recombinant vaccinia viruses that display the HIV type 1 envelope glycoprotein on the surface of infectious virions. E Katz ... B Moss AIDS Res Hum Retroviruses 1997 Nov; 13(17)1497-500. Score: 0.377 DNA vaccines for immunodeficiency viruses. H L Robinson AIDS 1997 ; 11 Suppl A()S109-19. Score: 0.376 New vaccines against measles and other viruses. F N Macnamara N Z Med J 1965 Aug; 64(396)442-3. Score: 0.376 Alphavirus DNA and particle replicons for vaccines and gene therapy. J M Polo ... T W Dubensky Dev Biol (Basel) 2000 ; 104()181-5. Score: 0.376 Adenoviruses as vectors for HIV vaccines. Víctor Raúl Gómez-Román ... Marjorie Robert-Guroff AIDS Rev 2003 Jul-Sep; 5(3)178-85. Score: 0.376 [Recombination of alpha-viruses during mixed infection in cultured cells. Formation of hybrid forms of RNA of Venezuelan equine encephalomyelitis virus and Karelian fever virus in the region of genes for nucleocapsid and envelope proteins] T M Sokolova ... N S Bystrov Vopr Virusol 1996 Nov-Dec; 41(6)245-52. Score: 0.376 Bichat guidelines for the clinical management of viral encephalitis and bioterrorism-related viral encephalitis. Philippe Bossi ... Georgios Gouvras Euro Surveill 2004 Dec; 9(12)E21-2. Score: 0.375 Genetically modified, live attenuated dengue virus type 3 vaccine candidates. Joseph E Blaney ... Stephen S Whitehead Am J Trop Med Hyg 2004 Dec; 71(6)811-21. Score: 0.375 Genetically engineered particulate virus-like structures and their use as vaccine delivery systems. P Roy Intervirology 1996 ; 39(1-2)62-71. Score: 0.375 Viruses as vectors. C J Bostock Vet Microbiol 1990 Jun; 23(1-4)55-71. Score: 0.375 Chimeric measles viruses with a foreign envelope. P Spielhofer ... H Y Naim J Virol 1998 Mar; 72(3)2150-9. Score: 0.374 Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. P Pushko ... J F Smith Vaccine 2000 Aug; 19(1)142-53. Score: 0.374 Yersinia pestis (plague) vaccines. Richard W Titball ... E Diane Williamson Expert Opin Biol Ther 2004 Jun; 4(6)965-73. Score: 0.374 Vaccination against herpesvirus, fiction or reality? B Morein ... M Merza Scand J Infect Dis Suppl 1991 ; 80()110-8. Score: 0.374 Ebola virus: the search for vaccines and treatments. J A Wilson ... M K Hart Cell Mol Life Sci 2001 Nov; 58(12-13)1826-41. Score: 0.374 Bioterrorism. Vaccines for biodefense: a system in distress. J Cohen ... E Marshall Science 2001 Oct; 294(5542)498-501. Score: 0.374 Alphavirus replicon particles as candidate HIV vaccines. Nancy L Davis ... Robert E Johnston IUBMB Life 2002 Apr-May; 53(4-5)209-11. Score: 0.373 A new approach to AIDS research and prevention: the use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines. T Haga ... M Hayami Microbiol Immunol 1998 ; 42(4)245-51. Score: 0.373 Hepatitis vaccines. C A Petruff ... S Chopra Dig Dis 1997 Jan-Apr; 15(1-2)1-22. Score: 0.373 Emerging viral infections in Australia. A J Daley ... D E Dwyer J Paediatr Child Health 2002 Feb; 38(1)1-3. Score: 0.373 Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates. W D Pratt ... A L Schmaljohn Vaccine 1998 May-Jun; 16(9-10)1056-64. Score: 0.373 Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera. J A McKeating ... P Balfe Virology 1996 Jun; 220(2)450-60. Score: 0.372 Recombinant viruses as vaccines and immunological tools. M S Rolph ... I A Ramshaw Curr Opin Immunol 1997 Aug; 9(4)517-24. Score: 0.372 Vaccines against persistent DNA virus infections. M R Wills ... J G P Sissons Br Med Bull 2002 ; 62()125-38. Score: 0.371 Strategies for AIDS vaccines. E J Stott ... G C Schild J Antimicrob Chemother 1996 May; 37 Suppl B()185-98. Score: 0.371 [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains] I V Kiseleva ... L G Rudenko Vopr Virusol 2003 Jul-Aug; 48(4)26-9. Score: 0.371 Susceptibility of mosquito and tick cell lines to infection with various flaviviruses. C H Lawrie ... E A Gould Med Vet Entomol 2004 Sep; 18(3)268-74. Score: 0.371 Glycosaminoglycan binding properties of natural venezuelan equine encephalitis virus isolates. Eryu Wang ... Scott C Weaver J Virol 2003 Jan; 77(2)1204-10. Score: 0.370 Future directions in vaccines: the payoffs of basic research. Sarah Landry ... Carole Heilman Health Aff (Millwood) 2005 May-Jun; 24(3)758-69. Score: 0.370 [Development of polymeric nanoparticles-based vaccine] Takami Akagi ... Mitsuru Akashi Nippon Rinsho 2006 Feb; 64(2)279-85. Score: 0.370 Recombinant viruses as tools to induce protective cellular immunity against infectious diseases. Carolina Damas Rocha ... Oscar Bruna-Romero Int Microbiol 2004 Jun; 7(2)83-94. Score: 0.370 Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Alexander A Rumyantsev ... Alexander G Pletnev Vaccine 2006 Jan; 24(2)133-43. Score: 0.369 Vaccine candidates in STD. Mark A Fletcher Int J STD AIDS 2002 Dec; 13 Suppl 2()38-41. Score: 0.369 [Immunogenic properties of foot-and-mouth vaccines] P Tekerlekov ... M Dilovski Vet Med Nauki 1983 ; 20(5-6)46-51. Score: 0.369 Immunology of viral respiratory tract infection in infancy. James E Crowe ... John V Williams Paediatr Respir Rev 2003 Jun; 4(2)112-9. Score: 0.369 Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. J A Mumford ... R F Cook Vaccine 1994 Jul; 12(9)857-63. Score: 0.368 Swinepox virus as a vaccine vector for swine pathogens. D N Tripathy Adv Vet Med 1999 ; 41()463-80. Score: 0.367 Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. H L Greenstone ... J T Schiller Proc Natl Acad Sci U S A 1998 Feb; 95(4)1800-5. Score: 0.367 Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge. Amanda E Calvert ... John T Roehrig J Gen Virol 2006 Feb; 87(Pt 2)339-46. Score: 0.367 Live attenuated Salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens. C E Hormaeche J Immunol Methods 1991 Aug; 142(1)113-20. Score: 0.366 Recombinant vaccinia viruses as live vaccines. G L Smith Haematol Blood Transfus 1987 ; 31()362-6. Score: 0.366 Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Igor M Belyakov ... Jay A Berzofsky Proc Natl Acad Sci U S A 2003 Aug; 100(16)9458-63. Score: 0.366 Failed to fetch article title! Article may not be available. Score: 0.364 DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza. C W Olsen Vet Microbiol 2000 May; 74(1-2)149-64. Score: 0.364 Development of bivalent rgp120 vaccines to prevent HIV type 1 infection. P W Berman AIDS Res Hum Retroviruses 1998 Oct; 14 Suppl 3()S277-89. Score: 0.363 Vaccine approaches currently in development. D Gold Body Posit 1998 Jul; 11(7)34-5. Score: 0.363 Herpes simplex virus vaccines. D I Bernstein ... L R Stanberry Vaccine 1999 Mar; 17(13-14)1681-9. Score: 0.362 A vaccine for HIV type 1: the antibody perspective. D R Burton Proc Natl Acad Sci U S A 1997 Sep; 94(19)10018-23. Score: 0.362 Alphavirus vectors for gene expression and vaccines. S Schlesinger ... T W Dubensky Curr Opin Biotechnol 1999 Oct; 10(5)434-9. Score: 0.362 Clinical experience with respiratory syncytial virus vaccines. Pedro A Piedra Pediatr Infect Dis J 2003 Feb; 22(2 Suppl)S94-9. Score: 0.362 Immunity to influenza A H9N2 viruses induced by infection and vaccination. X Lu ... J M Katz J Virol 2001 May; 75(10)4896-901. Score: 0.362 Preparation of inactivated vaccines against alphaviruses using Semliki Forest virus-white mouse as a model. I. Inactivation experiments and evaluation of double inactivated subunit vaccines. M Mussgay ... E Weiland Intervirology 1973 ; 1(4)259-68. Score: 0.361 Isolation of eastern equine encephalitis virus and West Nile virus from crows during increased arbovirus surveillance in Connecticut, 2000. William H Beckwith ... Donald Mayo Am J Trop Med Hyg 2002 Apr; 66(4)422-6. Score: 0.361 Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model. Lijuan Yuan ... Linda J Saif Vet Immunol Immunopathol 2002 Sep; 87(3-4)147-60. Score: 0.360 Targeting early events in T cell activation to construct improved vaccines. G S Buchan ... M A Baird Mol Immunol 2000 Jun; 37(9)545-52. Score: 0.360 Vaccines for adults in an age of terrorism. Michael S Simberkoff J Assoc Acad Minor Phys 2002 Jan; 13(1)19-22. Score: 0.360 Inducement of respiratory mucosal immunogenicity for nasal vaccine due to amine- and amide-inactivation of parainfluenza virus type 1, Sendai. T Miyamae Microbiol Immunol 1994 ; 38(12)937-41. Score: 0.360 Current immunizations for travel. Beth D Kirkpatrick ... W Kemper Alston Curr Opin Infect Dis 2003 Oct; 16(5)369-74. Score: 0.360 Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice. A B Ryzhikov ... E I Ryabchikova Biomed Sci 1991 ; 2(6)607-14. Score: 0.360 Eastern equine encephalomyelitis virus in relation to the avian community of a coastal cedar swamp. W J Crans ... J R McNelly J Med Entomol 1994 Sep; 31(5)711-28. Score: 0.359 Influenza vaccines generated by reverse genetics. K Subbarao ... J M Katz Curr Top Microbiol Immunol 2004 ; 283()313-42. Score: 0.359 Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review. T G Boyce ... G A Poland Biomed Pharmacother 2000 May; 54(4)210-8. Score: 0.359 Virus vaccines: principles and prospects. J L Melnick Bull World Health Organ 1989 ; 67(2)105-12. Score: 0.358 Possible approaches to develop vaccines against hepatitis A. E D'Hondt Vaccine 1992 ; 10 Suppl 1()S48-52. Score: 0.358 Immunity against eastern and western equine encephalomyelitis viruses. R J Byrne J Am Vet Med Assoc 1969 Jul; 155(2)365-8. Score: 0.358 Seed viruses containing novel avian HA and NA antigens for prevention against potential influenza pandemic. S Li ... E Patzer Dev Biol (Basel) 2002 ; 110()135-41. Score: 0.358 Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J E Johnson ... J K Rose J Virol 1997 Jul; 71(7)5060-8. Score: 0.357 HPV vaccines. Margaret Stanley Best Pract Res Clin Obstet Gynaecol 2006 Apr; 20(2)279-93. Score: 0.357 The pediatrician's role in influenza control. W P Glezen Pediatr Infect Dis 1986 Nov-Dec; 5(6)615-8. Score: 0.357 [Immunity of viruses and the effectiveness of vaccines. Mutation of viruses and effectiveness of vaccines--recombination and mutation] T Kurimura Nippon Rinsho 1987 Oct; 45(10)2225-8. Score: 0.357 Laboratory and clinical evaluation of new live influenza virus vaccines. Need for minimum requirements. C Huygelen Dev Biol Stand 1977 Jun 1-3; 39()155-60. Score: 0.356 Emerging melanoma vaccines. Jean-Claude Bystryn Expert Opin Emerg Drugs 2002 Oct; 7(2)213-21. Score: 0.356 Emerging viruses: the Bunyaviridae. R M Elliott Mol Med 1997 Sep; 3(9)572-7. Score: 0.356 Replication-defective HIV as a vaccine candidate. F Y Tung ... R C Montelaro AIDS Res Hum Retroviruses 1998 Sep; 14(14)1247-52. Score: 0.355 A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. Thomas C Heineman ... George Kemble J Infect Dis 2006 May; 193(10)1350-60. Score: 0.355 Effect of immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection. K N Masihi ... K Masek Vaccine 1990 Apr; 8(2)159-63. Score: 0.355 Venezuelan equine encephalitis virus infection of spiny rats. Anne-Sophie Carrara ... Scott C Weaver Emerg Infect Dis 2005 May; 11(5)663-9. Score: 0.354 Zoonotic implications of Hantaan-like viruses: an introduction. F W Quimby Lab Anim Sci 1987 Aug; 37(4)411-2. Score: 0.354 Substitution of hiv type-1 non-B env genes in C2, a subtype B cassette system, results in functional chimeric viruses. Natalie N Zheng ... Rod S Daniels AIDS Res Hum Retroviruses 2004 Sep; 20(9)964-71. Score: 0.354 DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Bertrand Bellier ... David Klatzmann Vaccine 2006 Mar; 24(14)2643-55. Score: 0.354 Evolutionary relationships and systematics of the alphaviruses. A M Powers ... S C Weaver J Virol 2001 Nov; 75(21)10118-31. Score: 0.354 Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J Li ... J Sodroski J Acquir Immune Defic Syndr 1992 ; 5(7)639-46. Score: 0.354 Japanese encephalitis: dev